サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654406

個別化医療アウトソーシング市場規模、シェア、動向分析レポート：フェーズ別、最終用途別、サービス別、タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
個別化医療アウトソーシング市場規模、シェア、動向分析レポート：フェーズ別、最終用途別、サービス別、タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年01月28日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向

世界の個別化医療アウトソーシング市場規模は2024年に1,120億8,000万米ドルと推定され、2025～2030年にかけてCAGR 12.47％で成長すると予測されています。

個別化医療の利点に関する意識の高まり、希少疾患、がん、感染症など様々な疾患における個別化医療の応用の増加、専門的な専門知識の必要性、サービスをアウトソーシングすることの利点などが、市場成長を促進する主要要因です。慢性疾患、希少疾患、感染症などの有病率の増加は、患者の転帰を向上させるため、これらの医薬品に対する需要をさらに高めています。米国がん協会の報告書「Cancer Facts & Figures 2023」によると、2023年の米国におけるがんによる死亡者数は約60万9,820人と予想され、同年には1.9人以上が診断されると予測されています。

個別化医療の応用はがん治療において著しく増加しており、これが市場成長の主要要因の一つとなっています。個別化医療または精密医療は、特定のがんの早期発見、がんリスクの高い人の特定、治療選択肢の評価、患者の健康に対する治療効果など、腫瘍学におけるいくつかの適応症に利用されています。これらの疾患の負担が増加するにつれて、個別化医療に対する需要も拡大すると予想されます。

さらに、CROとCDMOは、製薬会社の多くが医薬品開発・製造活動をこれらのアウトソーシング企業に委託することを選択するようになったため、過去数年間で大きな成長を遂げています。開発から製造に至るまで、個別化医療のあらゆる側面に対応する能力を社内で開発・維持するには、さまざまなリソースと投資が必要となります。そのため、これらの活動をアウトソーシングすることで、企業はニーズに応じた専門的な専門知識、インフラ、リソースを利用できるようになり、費用対効果の高いソリューションを提供できるようになります。さらに、前臨床段階や臨床段階での失敗など、個別化ソリューションの開発に伴う複雑さやリスクは大きなリスク要因となるが、CROは後期段階の開発や製造の複雑さを処理できるため、企業は業務を合理化し、効率を高めることができます。

個別化医療は、試行錯誤的な配合を減らし、副作用の回避に役立ち、医療の重要性を予防から反応へとシフトさせるなど、いくつかの利点があるため、近年その認知度は著しく高まっています。個別化医療は、臨床症状や徴候が現れる前であっても病気のリスクや存在を示すことができる分子マーカーを使用する能力を提供し、病気の早期治療を可能にし、それによって患者の転帰を改善します。同様に、患者が提供された治療や投薬に従わないことは、副作用（ADR）のような健康への悪影響につながる可能性があります。したがって、ADRの症例が増加すれば、人々の間でより良い治療オプションへの需要が高まり、個別化医療への需要がさらに高まることになります。例えば、米国国立衛生ラボ（NIH）が2024年1月に発表した紙製によると、2022年には米国で約125万件の重篤な副作用が発生し、約17万5,000人が死亡しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 個別化医療アウトソーシング市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 市場分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 個別化医療アウトソーシング市場：フェーズ別、推定・動向分析

  • セグメントダッシュボード
  • 世界の個別化医療アウトソーシング市場のフェーズ変動分析
  • 世界の個別化医療アウトソーシング市場規模と動向分析、フェーズ別、2018～2030年
  • 臨床
    • フェーズI
    • フェーズII
    • フェーズIII
    • フェーズIV
  • 前臨床

第5章 個別化医療アウトソーシング市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • 世界の個別化医療アウトソーシング市場の用途変動分析
  • 世界の個別化医療アウトソーシング市場規模と動向分析、用途別、2018～2030年
  • 腫瘍学
  • 希少疾患
  • 感染症
  • その他

第6章 個別化医療アウトソーシング市場：サービス別、推定・動向分析

  • セグメントダッシュボード
  • 世界の個別化医療アウトソーシング市場のサービス変動分析
  • 世界の個別化医療アウトソーシング市場規模と動向分析、サービス別、2018～2030年
  • 契約製造
  • 契約開発

第7章 個別化医療アウトソーシング市場：タイプ別、推定・動向分析

  • セグメントダッシュボード
  • 世界の個別化医療アウトソーシング市場のタイプ変動分析
  • 世界の個別化医療アウトソーシング市場規模と動向分析、タイプ別、2018～2030年
  • 阻害剤
  • モノクローナル抗体
  • 細胞・遺伝子治療
  • その他

第8章 個別化医療アウトソーシング市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 世界の個別化医療アウトソーシング市場の最終用途変動分析
  • 世界の個別化医療アウトソーシング市場規模と動向分析、最終用途別、2018～2030年
  • 製薬会社
  • バイオテクノロジー企業
  • その他

第9章 個別化医療アウトソーシング市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 企業/競合の分類
    • マーケットリーダー
    • 新興参入企業
  • 企業市況分析、2024年
  • 企業プロファイル
    • Parexel International（MA）Corporation
    • Syneos Health
    • Catalent, Inc
    • ICON
    • Lonza
    • Syngene International Limited
    • HCL Technologies Limited
    • Infosys Limited
    • Fujirebio
    • Aurigene Pharmaceutical Services Ltd.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global personalized medicine outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 6 Global personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 7 Global personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 12 North America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 13 North America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 17 U.S. personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 18 U.S. personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 20 Canada personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 21 Canada personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Canada personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 23 Canada personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 26 Mexico personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 27 Mexico personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 28 Mexico personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 31 Europe personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 32 Europe personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Europe personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Europe personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 36 Germany personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 37 Germany personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 38 Germany personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 39 Germany personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 41 UK personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 42 UK personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 43 UK personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 44 UK personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 46 France personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 47 France personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 48 France personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 49 France personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 51 Italy personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Italy personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 53 Italy personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 54 Italy personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 56 Spain personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 57 Spain personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 58 Spain personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 59 Spain personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 61 Denmark personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Denmark personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 63 Denmark personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 64 Denmark personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 66 Sweden personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 67 Sweden personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Sweden personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 69 Sweden personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Norway personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 72 Norway personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 73 Norway personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 74 Norway personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 81 China personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 82 China personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 83 China personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 84 China personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 85 China personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 87 Japan personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 88 Japan personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 89 Japan personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 90 Japan personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 92 India personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 93 India personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 94 India personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 95 India personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 97 South Korea personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 98 South Korea personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 99 South Korea personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 100 South Korea personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 102 Australia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 103 Australia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 104 Australia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 105 Australia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 107 Thailand personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 108 Thailand personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 109 Thailand personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 110 Thailand personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 113 Latin America personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 114 Latin America personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 115 Latin America personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 116 Latin America personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 118 Brazil personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 119 Brazil personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 120 Brazil personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 121 Brazil personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 124 Argentina personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 125 Argentina personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 126 Argentina personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA personalized medicine outsourcing market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 129 MEA personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 130 MEA personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 131 MEA personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 132 MEA personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 135 South Africa personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 136 South Africa personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 137 South Africa personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 144 UAE personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 145 UAE personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 146 UAE personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 147 UAE personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait personalized medicine outsourcing market, by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait personalized medicine outsourcing market, by application, 2018 - 2030 (USD Million)
  • Table 150 Kuwait personalized medicine outsourcing market, by Service, 2018 - 2030 (USD Million)
  • Table 151 Kuwait personalized medicine outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait personalized medicine outsourcing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Personalized Medicine Outsourcing Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Personalized Medicine Outsourcing Market: Phase Key Takeaways
  • Fig. 14 Global Personalized Medicine Outsourcing Market: Phase Movement Analysis
  • Fig. 15 Global Personalized Medicine Outsourcing Market, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 16 Global Personalized Medicine Outsourcing Market, for Phase I, 2018 - 2030 (USD Million)
  • Fig. 17 Global Personalized Medicine Outsourcing Market, for Phase II, 2018 - 2030 (USD Million)
  • Fig. 18 Global Personalized Medicine Outsourcing Market, for Phase III, 2018 - 2030 (USD Million)
  • Fig. 19 Global Personalized Medicine Outsourcing Market, for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 20 Global Personalized Medicine Outsourcing Market, for Preclinical, 2018 - 2030 (USD Million)
  • Fig. 21 Global Personalized Medicine Outsourcing Market: Application Key Takeaways
  • Fig. 22 Global Personalized Medicine Outsourcing Market: Application Movement Analysis
  • Fig. 23 Global Personalized Medicine Outsourcing Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 24 Global Personalized Medicine Outsourcing Market, for Rare Diseases, 2018 - 2030 (USD Million)
  • Fig. 25 Global Personalized Medicine Outsourcing Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 26 Global Personalized Medicine Outsourcing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Personalized Medicine Outsourcing Market: Type Key Takeaways
  • Fig. 28 Global Personalized Medicine Outsourcing Market, Type Movement Analysis
  • Fig. 29 Global Personalized Medicine Outsourcing Market, for Inhibitor Drugs, 2018 - 2030 (USD Million)
  • Fig. 30 Global Personalized Medicine Outsourcing Market, for Monoclonal Antibodies, 2018 - 2030 (USD Million)
  • Fig. 31 Global Personalized Medicine Outsourcing Market, for Cell & Gene Therapy, 2018 - 2030 (USD Million)
  • Fig. 32 Global Personalized Medicine Outsourcing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Global Personalized Medicine Outsourcing Market: End Use Key Takeaways
  • Fig. 34 Global Personalized Medicine Outsourcing Market, End Use Movement Analysis
  • Fig. 35 Global Personalized Medicine Outsourcing Market, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 36 Global Personalized Medicine Outsourcing Market, for Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 37 Global Personalized Medicine Outsourcing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 Regional Outlook, 2024 & 2030
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-350-7

Market Size & Trends:

The global personalized medicine outsourcing market size was estimated at USD 112.08 billion in 2024 and is projected to grow at a CAGR of 12.47% from 2025 to 2030. The increasing awareness regarding benefits of personalized medicine, increasing application of personalized medicine in various diseases, such as rare diseases, cancer, infectious diseases, and others, the requirement of specialized expertise, and the benefits of outsourcing the services are some of the major factors driving the market growth. The increasing prevalence of diseases such as chronic diseases, rare diseases and infectious diseases is further increasing the demand for these medicines as it offers enhanced patient outcomes. According to the American Cancer Society report, Cancer Facts & Figures 2023, cancer was expected to cause around 609,820 deaths in the U.S. in 2023 and was expected to diagnose over 1.9 people in the same year.

The applications of personalized medicine have significantly increased in cancer care, which is one of the major factors contributing to the market growth. Personalized medicine or precision medicine is utilized for several indications in oncology such as early detection of certain cancers, identifying people with higher cancer risk, evaluation of treatment alternatives, and effect of treatment on patient's health. As the burden of these diseases increase, the demand for personalized medicine is also anticipated to witness growth.

Furthermore, CROs and CDMOs have witnessed significant growth during the past few years as most of the pharmaceutical companies are opting to outsource their drug development and manufacturing activities to these outsourcing companies. Building and maintaining internal capabilities for all aspects of personalized medicine, from development to manufacturing, requires several resources and investments. Therefore, outsourcing these activities can allow companies to access specialized expertise, infrastructure, and resources according to their needs, thereby offering a cost-effective solution. Moreover, the complexity and risk associated with the development of personalized solutions, such as failures in the preclinical and clinical phases, offer a significant risk factor, while CROs can handle the complexities of later-stage development and manufacturing, allowing companies to streamline their operations and enhance their efficiency.

The awareness about personalized medicine has significantly increased in recent years owing to its several benefits, such as reducing trial and error prescribing, helping in avoiding adverse drug reactions, and shifting the medical importance from prevention to reaction. Personalized medicine offers the ability to use molecular markers that can indicate disease risk or presence even before clinical signs and symptoms appear, allowing for early treatments of diseases and thereby improving patient outcomes. Similarly, the patient's non-compliance with offered treatment and medication can lead to adverse health effects such as Adverse Drug Reactions (ADR), which have been on a significant rise in past years. Thus, increasing cases of ADRs would boost the demand for better treatment options among people further driving the demand for personalized medicine. For instance, according to an article published by the National Institute of Health (NIH) in January 2024, there were around 1.25 million serious adverse effects and approximately 175,000 deaths were recorded in the U.S. in 2022.

Global Personalized Medicine Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global personalized medicine outsourcing market report based on phase, application, service, type, end use, and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Rare Diseases
  • Infectious Diseases
  • Others
  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Contract Manufacturing
  • Contact Development
  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Inhibitor Drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Other Therapeutic Products
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information analysis
    • 1.3.2. Data validation & publishing
    • 1.3.3. Information Procurement
    • 1.3.4. Primary Research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Research Models
    • 1.6.1. Commodity Flow Analysis
    • 1.6.2. Bottom-up Approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Personalized Medicine Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic and rare diseases
      • 3.2.1.2. Increasing awareness about the benefits of personalized medicine
      • 3.2.1.3. Increasing application of personalized medicine in various diseases
      • 3.2.1.4. Requirement of specialized expertise for personalized medicine development and manufacturing
    • 3.2.2. Market restraints analysis
      • 3.2.2.1. Data privacy concerns
      • 3.2.2.2. Compliance issues with outsourcing
  • 3.3. Market Analysis Tools
    • 3.3.1. Porter's five forces analysis
    • 3.3.2. PESTEL analysis
    • 3.3.3. COVID-19 impact analysis

Chapter 4. Personalized Medicine Outsourcing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Personalized Medicine Outsourcing Market Product Movement Analysis
  • 4.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Phase I
      • 4.4.2.1. Phase I Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Phase II
      • 4.4.3.1. Phase II Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Phase III
      • 4.4.4.1. Phase III Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Phase IV
      • 4.4.5.1. Phase IV Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Personalized Medicine Outsourcing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Personalized Medicine Outsourcing Market Application Movement Analysis
  • 5.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.5. Rare Diseases
    • 5.5.1. Rare Diseases Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Personalized Medicine Outsourcing Market: Service Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Personalized Medicine Outsourcing Market Service Movement Analysis
  • 6.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 6.4. Contract Manufacturing
    • 6.4.1. Contract Manufacturing Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 6.5. Contact Development
    • 6.5.1. Contact Development Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Personalized Medicine Outsourcing Market: Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Personalized Medicine Outsourcing Market Type Movement Analysis
  • 7.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 7.4. Inhibitor Drugs
    • 7.4.1. Inhibitor Drugs Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5. Monoclonal Antibodies
    • 7.5.1. Monoclonal Antibodies Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6. Cell & Gene Therapy
    • 7.6.1. Cell & Gene Therapy Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Personalized Medicine Outsourcing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Personalized Medicine Outsourcing Market End Use Movement Analysis
  • 8.3. Global Personalized Medicine Outsourcing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical Companies
    • 8.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 8.5. Biotechnology Companies
    • 8.5.1. Biotechnology Companies Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 9. Personalized Medicine Outsourcing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. U.S. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Canada Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Mexico Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. UK Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Germany Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. France Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Italy Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Spain Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Competitive scenario
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Norway Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Competitive scenario
      • 9.5.8.3. Regulatory framework
      • 9.5.8.4. Sweden Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Competitive scenario
      • 9.5.9.3. Regulatory framework
      • 9.5.9.4. Denmark Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Japan Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Regulatory framework
      • 9.6.3.4. China Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Competitive scenario
      • 9.6.4.3. Regulatory framework
      • 9.6.4.4. India Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Competitive scenario
      • 9.6.5.3. Regulatory framework
      • 9.6.5.4. Australia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Competitive scenario
      • 9.6.6.3. Regulatory framework
      • 9.6.6.4. South Korea Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Competitive scenario
      • 9.6.7.3. Regulatory framework
      • 9.6.7.4. Thailand Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Brazil Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Argentina Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Competitive scenario
      • 9.8.2.3. Regulatory framework
      • 9.8.2.4. South Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Competitive scenario
      • 9.8.3.3. Regulatory framework
      • 9.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Competitive scenario
      • 9.8.4.3. Regulatory framework
      • 9.8.4.4. UAE Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Competitive scenario
      • 9.8.5.3. Regulatory framework
      • 9.8.5.4. Kuwait Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
    • 10.1.1. Market Leaders
    • 10.1.2. Emerging Players
  • 10.2. Company Market Position Analysis, 2024
  • 10.3. Company Profiles
    • 10.3.1. Parexel International (MA) Corporation
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Service benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Syneos Health
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Service benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Catalent, Inc
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Service benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. ICON
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Service benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Lonza
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Service benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Syngene International Limited
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Service benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. HCL Technologies Limited
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Service benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Infosys Limited
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Service benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Fujirebio
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Service benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Aurigene Pharmaceutical Services Ltd.
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Service benchmarking
      • 10.3.10.4. Strategic initiatives